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Abstract: MicroRNAs (miRNA) are a class of short noncoding RNA that play important roles in
controlling gene expression. Many miRNAs have been identified as being important regulators of
bone cell function, thus affecting the bone remodeling processes. In addition to being expressed in
specific tissues and exerting intracellular effects, miRNAs can enter the blood where they can be
taken up by other tissues. These circulating miRNAs (c-miRNA) also have clinical significance as
biomarkers of musculoskeletal diseases as they are tissue-specific, are stable and easily detectable, and
require minimally invasive procedures. This mini-review discusses miRNAs with regulatory roles in
bone metabolism and c-miRNA responses to acute bouts of resistance exercise. MiRNA responses
(e.g., upregulation/downregulation of expression) vary depending on the resistance exercise protocol
characteristics and the age of the participants. There are gaps in the literature that need to be
addressed as most of the resistance exercise studies focused on miRNAs that regulate skeletal muscle
in male participants.
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1. Introduction
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A rapidly emerging topic in osteoporosis research is the use of microRNAs (miRNA,
miR) as biomarkers of bone status since they are key regulatory players in bone remodeling [1–3]. MiRNAs are a class of short (21–22 nucleotides (nt) in length) noncoding RNA
that play important roles in controlling gene expression; specifically as negative regulators of gene expression [4]. A large number of miRNAs are important regulators of bone
cell function, with some miRNAs promoting or suppressing bone formation and others
promoting or suppressing bone resorption [1,3]. In addition to being expressed in specific
tissues and having intracellular effects, miRNAs can enter into the blood in response to
various stimuli including tissue injury and mechanical stress. These circulating miRNAs
(c-miRNA) have clinical significance as biomarkers of musculoskeletal diseases as they are
tissue-specific, are stable and easily detectable, and require minimally invasive procedures
(e.g., venous blood sample) [2]. Recent findings documenting dysregulated miRNAs in
the serum of osteoporosis patients [5–7], have generated much excitement as they support
the use of circulating miRNAs as biomarkers for bone loss and osteoporosis [2] as well as
highlight their therapeutic potential for bone disease [8] (Figure 1).
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growing number of MiRNAs have been identified to regulate osteoblastogenesis and bone
formation by targeting inhibitors of osteogenesis or osteogenic factors [3]. Some MiRNAs
stimulate osteoblastogenesis, such as miR-15b, -20a, whereas some MiRNAs inhibit osteoblastogenesis, such as miR-23a-3p, -100-5p, and -133a-3p. This occurs primarily through
regulating BMP-RUNX2 (Runt-Related Transcription Factor 2) and Wnt (Wingless-Type
MMTV Integration Site Family) signaling pathways. For example, miR-100-5p directly
targets BMPR2 (BMP receptor type II) and inhibits osteoblastogenesis. Research on the role
of miRNAs in osteocytes is in its early stages, however, miRNAs are expressed in osteocytes

Osteology 2022, 2

13

and have been shown to regulate osteocyte differentiation [15]. MiRNAs also regulate the
differentiation and proliferation of chondrocytes; miR-125b-5p is reported to stimulate the
differentiation of chondrocytes in mouse by repressing an inhibitor of chondrogenesis [16].
Table 1. Select MiRNAs with Bone Cell Regulatory Effects.
MiRNA
miR-21-5p
miR-23a-3p
miR-100-5p
miR-125b-5p
miR-126-3p
miR-133a-3p
miR-148a-3p

Target Gene

Pathway/Enzyme

Biological Effect

SMAD7
PDCD4
RUNX2
SMAD3
BMPR2
SMAD1
BMPR
OSX
MMP13
RUNX2
CXCL11
KDM6B
MAFB

BMP, TGF-β
c-Fos

Promote OB differentiation
Promote OC differentiation
Suppress OB differentiation
Suppress OB differentiation
Suppress OB differentiation
Suppress OB differentiation
Suppress OB differentiation
Suppress OB differentiation
Suppress OC differentiation
Suppress OB differentiation
Promote OC differentiation
Suppress OB differentiation
Promote OC differentiation

TGF-β
BMP
BMP
BMP
RUNX2
Matrix Degeneration
Rank
TGF-β
Rank

Modified from [3,5]. OB—osteoblast; OC—osteoclast; SMAD7—Small Mothers Against ecapentaplegic 7; BMP—
Bone Morphogenetic Protein; TGF-β—Transforming Growth Factor-Beta; DCD4—Programmed Cell Death
Protein 4; RUNX2—Runt-related Transcription Factor 2; SMAD3—Small Mothers Against Decapentaplegic 3;
BMPR2—BMP receptor type II; BMPR—BMP receptor; SMAD1—Small Mothers Against Decapentaplegic 1; OSX—
Osterix; MMP13—Matrix Metalloproteinase 13; CXCL11—C-X-C Motif Chemokine Ligand 11; KDM6B—Lysine
Demethylase 6B; AFB—V-maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog B.

MiR-21-5p, a widely studied miRNA, is ubiquitously expressed and has regulatory
roles in both osteoblast and osteoclast activities [2,3,17,18]. MiR-21-5p promotes bone
formation by inhibiting SMAD7 (Small Mothers Against Decapentaplegic 7), a protein that
inhibits osteoblast differentiation via the BMP and TGF-β (Transforming Growth FactorBeta) pathways. MiR-21-5p also promotes osteoclastogenesis via a positive feedback loop
involving c-Fos, a factor that promotes osteoclast formation, and PDCD4 (Programmed
Cell Death Protein 4), a protein that acts to inhibit osteoclast formation through c-Fos
inhibition [17,19]. In the positive feedback loop, c-Fos upregulates miR-21-5p expression,
which then suppresses PDCD4 expression, thereby reducing its inhibitory effect on c-Fos
(Figure 2A) [20]. Estrogen deficiency in postmenopausal women upregulates miR-21-5p,
which acts to suppress the transcription of FASL (Fas Ligand) [21]. As a result, osteoclast
apoptosis is inhibited, promoting bone resorption activity. Another miRNA, miR-23a-3p
targets the RUNX2 and SMAD3 (Small Mothers Against Decapentaplegic 3) pathways,
inhibiting osteoblast differentiation [22], thus high levels of miR-23a-3p inhibit bone formation, and the net imbalance favors bone resorption (Figure 2B). We recently reported a
positive relationship between miR-23a-3p and the bone resorption marker, TRAP5b (Transforming Growth Factor-Beta), in postmenopausal women that may be attributed to their
Osteology 2022, 1, FOR PEER REVIEW
4
regulatory roles on bone resorption since high serum TRAP5b concentrations indicate a
greater number of osteoclasts, which favors bone resorption [23].

Figure
2. MiR-21-5p
regulation
of osteoclastogenesis
(Panel A) and miR-23a-3p
regulation
of osteoFigure
2. MiR-21-5p
regulation
of osteoclastogenesis
(Panel A)
and miR-23a-3p
regulation of osblast differentiation (Panel B). PDCD4—Programmed Cell Death Protein 4; FASL—Fas Ligand;
teoblast differentiation (Panel B). PDCD4—Programmed Cell Death Protein 4; FASL—Fas Ligand;
RUNX2—Runt-Related Transcription Factor 2.

RUNX2—Runt-Related Transcription Factor 2.

4. MiRNAs and Osteoporosis
MiRNAs regulate osteogenesis and are associated with bone diseases such as osteoporosis (refer to review [3]) and may serve as biomarkers for osteoporosis. Wang et al. [24]
measured miRNAs in circulating monocytes in 20 postmenopausal women. The cohort
was dichotomized into high and low BMD groups and compared for miRNA expression
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4. MiRNAs and Osteoporosis
MiRNAs regulate osteogenesis and are associated with bone diseases such as osteoporosis (refer to review [3]) and may serve as biomarkers for osteoporosis. Wang et al. [24]
measured miRNAs in circulating monocytes in 20 postmenopausal women. The cohort
was dichotomized into high and low BMD groups and compared for miRNA expression
levels. Of the miRNAs assessed, miR-133a-3p was expressed significantly higher in the
low BMD group. The target for miR-133a-3p in bone is RUNX2, and higher levels in tissue
would have a negative impact on bone formation.
Seeliger et al. [5] analyzed circulating and bone tissue miRNAs in osteoporotic (n = 10)
and non-osteoporotic (n = 10) patients with hip fractures. In the two sample types, 5 miRNAs
(miR-21-5p, -23a-3p, -24, -100-5p, -125b-5p) were expressed higher in osteoporotic patients.
MiR-21-5p may affect bone through inhibition of PDCD4, which allows for osteoclast
survival. MiR-23a-3p and -24 are implicated in inhibition of RUNX2 for osteocyte formation. MiR-100-5p may negatively affect bone formation by inhibiting BMPR2, thus
halting the growth of pre-osteoblasts into mature osteoblasts. MiR-125b-5p may also affect
formation by inhibiting mesenchymal stem cell differentiation towards an osteoblastic
lineage. Weilner at al. [25] also assessed miRNAs in osteoporotic fracture patients. Serum
samples from 37 postmenopausal women (>65 years) were collected, 19 of which had
recent fractures due to osteoporosis. Samples were taken within two weeks of surgery.
Differentially expressed miRNAs included three upregulated (miR-10a-5p, 10b-5p, -22-3p)
and three downregulated (miR-133b -328-3p, let-7g-5p). A validation cohort was also used
to validate the differentially expressed miRNAs. It was found that only miR-22-3p, -328-3p
and let-7g-5p reached significance. In the case of miR-22-3p, the first study saw significant
upregulation while the validation cohort had significant downregulation. Of note, there
were no differences between fracture patients and controls for miR-21-5p. Panach et al. [6]
assessed c-miRNA in eight osteoporotic fracture patients (mean 80 years) compared to
five controls with osteoarthritis. They found that miR-122-5p, -125-5p, -21-5p were significantly upregulated in the fracture patients. MiR-21-5p was highly correlated with the
bone resorption marker, CTX-I (C-telopeptide of Type I collagen cross-links) and several
miRNAs (miR-21-5p, -125b-5p, -122-5p, -210) were positively correlated with bone formation markers (osteocalcin, bone-specific alkaline phosphatase). Although miR-21-5p can
have an osteogenic effect, it appears that in fracture patients, miR-21-5p serves to improve
osteoclastic function to a greater degree. Kelch et al. [7] found that miR-21-5p expression
was higher in both serum and in bone tissue of male and female patients with osteoporotic
fractures versus normal controls, suggesting a role for miR-21-5p in bone loss. Both cultured
osteoclast and osteoblast cells from bone tissue of osteoporotic fracture patients showed
upregulation of miR-21-5p expression.
In a recent study, we assessed circulating miRNAs in 75 postmenopausal women aged
60–85 years based on osteoporosis and sarcopenia status [23]. We measured miR-1-3p, -21-5p,
-23a-3p, -24-3p, -100-5p, -125b-5p, -133a-3p, -206, miRNAs associated with targets in muscle
and bone, and the bone resorption markers, CTX-I and TRAP5b. There were no significant differences in c-miRNA expression between osteoporotic and non-osteoporotic and sarcopenic
and non-sarcopenic participants; however, there were potentially biologically relevant differences in fold changes of miR-21-5p and miR-23a-3p, which were upregulated in osteoporotic
women, and in miR-125b-5p which was downregulated in the osteoporotic group.
5. MiRNAs and Mechanical Loading
In vitro studies have shown that mechanical loading changes miRNA expression,
which in turn, may be important regulatory mechanisms for the exercise-induced adaptations in bone metabolism [26]. Cell line studies provide evidence that miR-21-5p is sensitive
to mechanical loading as it was upregulated in human periodontal stem cells by a stretch
load [27] but downregulated in MC3T3-E1 cells by fluid shear stress promoting osteogenic
differentiation [28]. In mice, miR-21-5p deficiency inhibited osteoclast function and bone
resorption leading to increased trabecular bone accrual [17].
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5.1. Skeletal Muscle MiRNAs
MiRNAs are involved in the regulation of hypertrophy and other muscular adaptations. Table 2 shows a summary of skeletal muscle and serum/plasma miRNA responses
to acute bouts of resistance exercise studies in humans. Drummond et al. [29] compared
miRNA expression in skeletal muscle following acute resistance exercise and essential
amino acids ingestion in young (mean 29 years) and older (mean 70 years) men. MiR-1
expression was downregulated in young but not in older men following the exercise stimulus, indicating that aging results in a dysregulated miRNA response after an anabolic
stimulus. Rivas et al. [30] also compared the skeletal muscle miRNA responses to acute
resistance exercise in younger and older men. Similar to Drummond et al. [29], they found
that alterations in miRNA expression were age-dependent, as a large number of miRNA
were downregulated and 1 miRNA (miR-486-5p) upregulated in young men, whereas there
were no miRNA changes in skeletal muscle of older men after the resistance exercise bout.
Telles et al. [31] compared skeletal muscle miRNA responses in young men to three
types of acute exercise protocols; resistance exercise, high-intensity interval exercise, and
both resistance and high-intensity interval exercise performed concurrently. They used a
targeted approach for the miRNA analysis, selecting 8 miRNAs with known regulatory
roles in skeletal muscle development. Their main findings were that 7/8 miRNAs were
upregulated up to 8 h after acute exercise, with 6 miRNA (miR-1-3p, -133a-3p, -133b3p, -181a-3p, -378a-5p, -486) showing similar responses for all 3 exercise protocols, and
2 miRNAs (miR-23a-3p, -206) having greater changes in expression for the resistance
exercise compared to the high-intensity interval exercise protocol.
5.2. Circulating MiRNAs
Sawada et al. [32] assessed c-miRNA responses in 12 young men (~29 years) performing bench press and bilateral leg press. Participants performed five sets of ten repetitions at
70% 1 RM and had serum samples taken before, immediately after, 60 min, 1 day, and 3 days
after exercise. There was no significant change for miR-133 nor miR-21-5p post-exercise,
only downregulation of miR-146a and miR-221 three days post-exercise and upregulation
of miR-149a 24 h post-exercise. MiR-21-5p had a weak positive correlation with the catecholamines, epinephrine and norepinephrine, and testosterone and IGF-1 were weakly
positively correlated with miR-222.
C-miRNA expression changes to acute exercise may be attenuated by aging. Margolis et al. [33]
reported different patterns of c-miRNA expression in response to acute high intensity
resistance exercise with aging as c-miRNA profiles were downregulated in older men
but upregulated in younger men. Three miRNAs, miR-19b-3p, -206, -486, significantly
predicted skeletal muscle aging. Of the 10 c-miRNA that were differentially expressed in
young versus older men, 6 (miR-19a-3p, -19b-3p, -20a-5p, -26b-5p, -143-3p, -195-5p) were
associated with inhibition of the PI3K-Akt pathway, which would increase activation of the
Akt-mTOR pathway and increase cellular protein synthesis.
D’Souza et al. [34] observed the effects of an acute resistance exercise bout on the
expression of miRNAs in skeletal muscle tissue and plasma in 9 healthy young males.
Subjects performed 6 sets of 8–10 repetitions for leg press and 8 sets of 8–10 repetitions
for knee extension. Samples were collected pre, 2 h, and 4 h post-exercise. From skeletal
muscle biopsy, miR-133a-3p, -206a increased 2 h post- and miR-146a-5p increased 4 h
post-exercise. MiR-23a-3p decreased 2 h post- and further decreased 4 h post-exercise. Of
the c-miRNA, miR-133a-3p and -149-5p were elevated from baseline, while miR-1, -208a,
and -499 were undetected. Only miR-133a-3p had increased expression in both plasma and
skeletal muscle tissue and may serve as a marker for muscle damage.
Cui et al. [35] assessed the time-course of c-miRNA expression from three different resistance exercise protocols in young men. The three protocols consisted of five exercises: bench
press, squat, pulldown, overhead press, and standing dumbbell curl and were performed at
different volumes and intensities. The strength-endurance (SE) group performed three sets
of 16–20 repetitions at 40% 1RM with one-min rest intervals. The muscular hypertrophy
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(MH) group performed three sets of 12 repetitions at 70% of 1RM with two-min rest intervals.
The maximum strength (MS) group performed four sets of six repetitions at 90% of 1RM with
three-min rest intervals. For the SE group, miR-532 fold changes increased 1 h post-exercise
and remained elevated 24 h later while miR-208b decreased immediately post-exercise and
remained depressed. The MH group showed decreased expression for miR-21, and -133a,
immediately post-exercise, and miR-221 1 h post-exercise. MiR133b was upregulated 24 h
post-exercise, while miR-181a and miR-206 were upregulated 1 h post-exercise, then returned to baseline 24 h later. For the MS group, miR-133a significantly decreased expression
immediately post- and returned to baseline 1 h post-exercise. MiR-133b increased expression
from immediately post- to 1 h post-exercise. The authors concluded that miR-133a may
be a potential biomarker of physiological muscle strain for resistance exercise at very high
intensities (e.g., 90% 1RM). The changes seen in miR-21 may be indicative of an initial
pro-inflammatory response, followed by an anti-inflammatory response.
Evaluating c-miRNA responses to exercise may provide insight into the potential
benefits of exercise in ameliorating the negative effects of aging on musculoskeletal health.
There is a paucity of data in the literature on c-miRNA responses to acute exercise in postmenopausal women. We recently studied the effects of acute resistance exercise and wholebody vibration on expression of selected c-miRNAs in physically active postmenopausal
women aged 65–76 years [36]. This randomized crossover design study compared c-miRNA
responses to a bout of resistance exercise (RE) (3 sets 10 reps 70% 1 repetition maximum
(1RM), 5 exercises) and a bout of whole-body vibration (WBV) (5 sets 1 min bouts 20 Hz
3.38 mm peak to peak displacement. We targeted 4 c-miRNAs (miR-21-5p, -23a-3p, -133a-3p,
-148a-3p) that have been shown in the literature to regulate bone metabolism. The main
finding was that c-miR-21-5p expression was downregulated from 60 min post to 24 h
post-exercise for only the whole-body vibration protocol. Absolute changes in the bone
resorption marker (TRAP5b) were negatively correlated with c-miR-21-5p fold changes
for both whole-body vibration and resistance exercise modalities and there were significant moderate to strong negative correlations between baseline c-miRNAs and bone
status variables. Based on our findings, whole-body vibration induces a sufficient mechanical stimulus for altering c-miR-21-5p expression. The lack of c-miRNA responses
to the high intensity resistance exercise protocol may be related to the older age of the
postmenopausal women, since previous studies [29,30,33] have reported age-associated
differences in miRNA responses to a resistance exercise stimulus.
Table 2. MiRNA Responses to Acute Resistance Exercise (RE) Protocols.

Study

Drummond et al. [29]

Sawada et al. [32]

Rivas et al. [30]

RE Protocol

Target
Population

Sample

Leg extension 8 sets
10 reps 70% 1RM

Young men
(n = 6)
Older men
(n = 6)

Muscle

Bench press
Leg Press
5 sets 10 reps
70% 1RM

Young men
(n = 12)

Serum

Bilateral Knee
Extension
3 sets 10 reps
80% 1RM

Young men
(n = 8)
Older men
(n = 8)

Muscle

Upregulation

MiRNA
Responses
Downregulation

No Change

Young only
miR-1

Young miR-133a
miR-206
All in older men

miR-149

miR-146a
miR-221

Young only
miR-486-5p

Young only
miR-23b-3p
-24-3p, -26a-3p
-27a-3p, -27b-3p
-29c-3p, -30a-5p
-30d-5p, -95-3p
-126-3p, -133a
-133b, -140-3p
-181a-3p, -378a-5p

All in older men
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Table 2. Cont.

Study

RE Protocol

Target
Population

Margolis et al. [33]

Bilateral Knee
Extension, Leg Press
3 sets 10 reps
80% 1RM

Young men
(n = 9)
Older men
(n = 9)

D’Souza et al. [34]

Leg press
6 sets 8–10 reps
80% 1RM
Knee extension
8 sets 8–10 reps
80% 1RM

Cui et al. [35]

Bench press, Squat,
Pull-down, Overhead
Press, Dumbbell Curl
Hypertrophy
3 sets 12 reps 70% 1RM
Strength
4 sets 6 reps
90% 1RM
Strength Endurance
3 sets 16–20 reps
40% 1RM

Telles et al. [31]

Leg press
Knee extension
4 sets 8–12 RM
High-intensity interval
exercise (HIIE)
Concurrent resistance
and high-intensity
interval exercise (CON)

Buchanan [36]

Leg press
Shoulder press
Lat pulldown
Knee extension
Hip adduction
3 sets 10 reps
70–75% 1RM
Whole-body
vibration (WBV)
5–1 min sets
3.38 mm peak-to-peak
displacement
2.7 g

Young men
(n = 9)

Young men
(n = 45)

Young men
(n = 9)

Postmenopausal
women (n = 10)

Sample

Upregulation

MiRNA
Responses
Downregulation

Serum

Young
miR-221-3p
-222-3p
-206

Older
miR-31-5p
-124-3p, -211-5p
-375

Muscle
Plasma

Muscle
miR-23a-3p,
-133a-3p,
-146a-5p,
-206a, -378b
-486-5p
Plasma
miR-133a-3p
-149-5p

Plasma

Hypertrophy
miR-133b
-181a, -206
Strength
miR-133b
StrengthEndurance
miR-532

Muscle

all 3 protocols
miR-1-3p
-133a-3p
-133b-3p
-181a-3p
-486,
RE > HIIE, CON
miR-23a-3p,-206

Serum

No Change

Hypertrophy
miR-21
-133a, -221
Strength
miR-133a
StrengthEndurance
miR-208b

all 3 protocols
miR-378a-5p

WBV only
miR-21-5p

all for RE

miR—MicroRNA; RM—Repetition Maximum.

6. Conclusions
The assessment of miRNAs, particularly in the blood, is a rapidly growing area
of research that may increase the understanding of the regulatory roles of miRNAs in
disease pathology and in physiological responses of tissues to exercise. Figure 3 depicts
a theoretical model for miRNA and bone formation responses to the mechanical strain
induced by skeletal muscle contraction during resistance exercise. To date, resistance
exercise studies have focused on miRNAs regulating muscle tissue, not bone tissue, and
most of the studies have been conducted in men. The available data suggest that miRNAs
are differentially expressed in young versus older participants in response to resistance
exercise. There are gaps in the literature that need to be addressed, specifically more
information is needed on bone-specific miRNA responses to resistance exercise, and more
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studies need to be conducted in women, especially postmenopausal women who are at
greater risk for osteoporosis.

Figure 3. Theoretical model for resistance exercise effects on bone formation. miRNAs—microRNAs;
Figure 3. Theoretical model for resistance exercise effects on bone formation. miRNAs—mi− downregulation;
+ upregulation.
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